References
- Oberman BS, Patel VA, Cureoglu S, et al. The aetiopathologies of Ménière's disease: a contemporary review. Acta Otorhinolaryngol Ital. 2017;37:250–263.
- Lopez-Escamez JA, Carey J, Chung WH, et al. Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS); Korean Balance Society. Diagnostic criteria for Menière's disease. J Vestib Res. 2015;25:1–7.
- Magnan J, Özgirgin ON, Trabalzini F, et al. European position statement on diagnosis, and treatment of Meniere's disease. Int Adv Otol. 2018;14:317–321.
- Takeda T, Takeda S, Kakigi A, et al. Hormonal aspects of Ménière’s disease on the basis of clinical and experimental studies. ORL J Otorhinolaryngol Relat Spec. 2010;71:1–9.
- Katagiri Y, Takumida M, Hirakawa K, et al. Long-term administration of vasopressin can cause Ménière's disease in mice. Acta Otolaryngol. 2014;134:990–1004.
- Wangemann P. K(+) cycling and its regulation in the cochlea and the vestibular labyrinth. Audiol Neurootol. 2002;7:199–205.
- Kim BG, Kim JY, Jung J, et al. β1- and β2-adrenergic stimulation-induced electrogenic transport by human endolymphatic sac epithelium and its clinical implications. Sci Rep. 2017;7:42217.
- Fessenden JD, Schacht J. The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology. Hear Res. 1998;118:168–176.
- Mittal R, Bencie N, Shaikh N, et al. Role of cyclic nucleotide phosphodiesterases in inner ear and hearing. Front Physiol. 2017;8:1–3.
- Degerman E, In 't Zandt R, Pålbrink AK, et al. Vasopressin induces endolymphatic hydrops in mouse inner ear, as evaluated with repeated 9.4 T MRI. Hear Res. 2015;330:119–124. Dec
- Degerman E, In 't Zandt R, Pålbrink A, et al. Inhibition of phosphodiesterase 3, 4, and 5 induces endolymphatic hydrops in mouse inner ear, as evaluated with repeated 9.4T MRI. Acta Otolaryngol. 2017;137:8–15.
- Salt AN, Plontke SK. Endolymphatic hydrops: pathophysiology and experimental models. Otolaryngol Clin North Am. 2010;43:971–983.
- Qin L, Zhang B, Wang Q, et al. Effect of aldosterone on cochlear Af9 expression and hearing in guinea pig. Acta Otolaryngol. 2017;137:903–909.
- Gross ND, Kempton JB, Trune DR. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice. Laryngoscope. 2002;112:298–303.
- Mori N, Miyashita T, Inamoto R, et al. Ion transport its regulation in the endolymphatic sac: suggestions for clinical aspects of Meniere's disease. Eur Arch Otorhinolaryngol. 2017;274:1813–1820.
- Ahmad F, Murata T, Simizu K, et al. Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets. Oral Dis. 2015;21(1):e25–e50.
- Stefan E, Wiesner B, Baillie GS, et al. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells. J Am Soc Nephrol. 2007;18:199–212.
- Hermidorff MM, de Assis LV, Isoldi MC. Genomic and rapid effects of aldosterone: what we know and do not know thus far. Heart Fail Rev. 2017;22:65–89.
- Eckhard AH, Zhu M, O'Malley JT, et al. Inner ear pathologies impair sodium-regulated ion transport in Meniere's disease. Acta Neuropathol. 2019;137:343–357.
- Mittal R, Aranke M, Debs LH, et al. Indispensable role of ion channels and transporters in the auditory system. J Cell Physiol. 2017;232:743–758.